Publication / Source: Bioanalysis 1(6)
Authors: Abbott WR
“…as many contract research organizations seem to have reduced workflow, it would appear that the reduction in business from the small pharmaceutical/biotechnology companies must be more significant…”
It is important to understand that this article is written from the perspective of a scientist rather than an economist. Successful bioanalysis is accomplished through a logical sequence of events prior to arriving at the end point. In order to assess the impact of the current economic situation on bioanalysis, it is necessary to use the same logical thought processes as would be applied to regular bioanalytical problem solving. Therefore, this article attempts to set in context the general economic downturn, the impact of this on pharmaceuticals/biotechnology and the additional complexity of multiple patent expiries, before attempting to summarize the effect of all of this on bioanalysis and bioanalytical outsourcing.